Several clinical studies have shown that RNF2 is upregulated in several types of human cancer, including breast, nasopharyngeal, pancreatic, and lung carcinomas, which are associated with increased tumor growth and poor outcome [21, 22]. Here, RNF2 is linked to cancer.